Vitamin D status and vitamin D receptor gene polymorphisms and susceptibility to type 1 diabetes in Egyptian children

Gene

Volumn 536, Issue 2, 2014, Pages 430-434

  Abd Allah, Somia H ^a   Pasha, Heba F ^a   Hagrass, Hoda A ^b   Alghobashy, Ashgan A ^a  

^a ZAGAZIG UNIVERSITY   (Egypt)

^b Zagazig University   (Egypt)

Author keywords

Gene polymorphism; Type 1 diabetes mellitus; Vitamin D; Vitamin D receptor

Indexed keywords

25 HYDROXYVITAMIN D; VITAMIN D; VITAMIN D RECEPTOR;

ADULT; APAI GENE; ARTICLE; BSMI GENE; CHILD; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; EGYPT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOKI GENE; GENE; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK; SCHOOL CHILD; TAQI GENE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; YOUNG ADULT;

25(OH)D; 25-HYDROXYVITAMIN D; BMI; BODY MASS INDEX; GENE POLYMORPHISM; PCR-RFLP; POLYMERASE CHAIN REACTION RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISMS; SNPS; T1DM; TYPE 1 DIABETES MELLITUS; VDR; VITAMIN D; VITAMIN D RECEPTOR;

ADOLESCENT; ALLELES; CHILD; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; POLYMORPHISM, GENETIC; RECEPTORS, CALCITRIOL; RISK; VITAMIN D;

EID: 84892439858     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.12.032     Document Type: Article

References (46)

1. Ban Y., Taniyama M., Yanagawa T. Vitamin D receptor initiation codon polymorphism influences genetic susceptibility to type 1 diabetes mellitus in the Japanese population. BMC Med. Genet. 2001, 2:7-13.
2. Barrett J.C., et al. Genome-wide association study and meta-analysis finds over 40 loci affect risk of type 1 diabetes. Nat. Genet. 2009, 42:703-707.
3. Bener A., Al-Ali M., Hoffmann G.F. High prevalence of vitamin D deficiency in young children in a highly sunny humid country: a global health problem. Minerva Pediatr. 2009, 61:15-22.
4. Bener A., et al. High prevalence of vitamin D deficiency in type 1 diabetes mellitus and healthy children. Acta Diabetol. 2009, 46:183-189.
5. Bierschenk L., Alexande J., Wasserfall C., Haller M., Schatz D., Atkinson M. Vitamin D levels in subjects with and without type 1 diabetes residing in a solar rich environment. Diabetes Care 2009, 32:1977-1979.
6. Bland J.M., Altman D.G. Multiple significance tests: the Bonferroni method. BMJ 1995, 310:170-171.
7. Chang T.J., et al. Vitamin D receptor gene polymorphism influences susceptibility to type 1 diabetes mellitus in the Taiwanese population. Clin. Endocrinol. 2000, 52:575-580.
8. Chen H., et al. AluYb8 insertion in the MUTYH gene is related to increased 8-OHdG in genomic DNA and could be a risk factor for type2 diabetes in a Chinese population. Mol. Cell. Endocrinol. 2011, 332:301-305.
9. Danescu L.G., Levy S., Levy J. Vitamin D and diabetes mellitus. Endocrinology 2009, 35:11-17.
10. Gordon C.M., et al. Prevalence of vitamin D deficiency among healthy infants and toddlers. Arch. Pediatr. Adolesc. Med. 2008, 162:505-512.
11. Greer R.M., et al. Australian children and adolescents with type 1 diabetes have low vitamin D levels. Med. J. Aust. 2007, 187:59-60.
12. Guja C., et al. The study of CTLA-4 and vitamin D receptor polymorphisms in the Romanian type 1 diabetes population. J. Cell. Mol. Med. 2002, 6:75-81.
13. Guo S.W., Magnuson V.L., Schiller J.J. Meta-analysis of vitamin D receptor polymorphisms and type 1 diabetes: a huge review of genetic association studies. Am. J. Epidemiol. 2006, 146:711-724.
14. Györffy B., et al. Gender-specific association of vitamin D receptor polymorphism combinations with type 1 diabetes mellitus. Eur. J. Endocrinol. 2002, 147:803-808.
15. Holick M.F. Diabetes and vitamin D connection. Curr. Diabet. Rep. 2008, 8:393-398.
16. Ioannidis J.P., Ntzani E.E., Trikalinos T.A. "Racial" differences in genetic effects for complex diseases. Nat. Genet. 2004, 36:1312-1318.
17. Jabbar Z., et al. High prevalence of vitamin D deficiency in North Indian adults is exacerbated in those with chronic kidney disease. Nephrology 2009, 14:345-349.
18. Jannera M., Ballinarib P., Mullisa P.E., Flücka C.E. High prevalence of vitamin D deficiency in children and adolescents with type 1 diabetes. Swiss Med. Wkly. 2010, 140:w13091. 10.4414/smw.2010.13091.
19. Lemire J. 1,25 vitamin D3-a hormone with immunodulatory properties. J. Rheumatol. 2000, 59:24-27.
20. Lemos M.C., et al. Lack of association of vitamin D receptor gene polymorphisms with susceptibility to type 1 diabetes mellitus in the Portuguese population. Hum. Immunol. 2008, 69:134-138.
21. Littorin B., et al. Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS). Diabetologia 2006, 49:2847-2852.
22. Lohmueller K.E., Pearce C.L., Pike M., Lander E.S., Hirschhorn J.N. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat. Genet. 2003, 33:177-182.
23. Mathieu C., et al. Vitamin D and 1,25-dihydroxyvitamin D3 as immunomodulators in the immune system. J. Steroid Biochem. Mol. Biol. 2004, 89:449-452.
24. Mc Dermott M.F., Ramachandran A., Ogunkolade B.W. Allelic variation in the vitamin D receptor influences susceptibility to IDDM in Indian Asians. Diabetologia 1997, 40:971-975.
25. Misra M., Pacaud D., Petryk A., Collett-Solberg P.F., Kappy M. Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics 2008, 122:398-417. Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society.
26. Mohammadnejad Z., et al. Association between vitamin D receptor gene polymorphisms and type 1 diabetes mellitus in Iranian population. Mol. Biol. Rep. 2012, 39:831-837.
27. Mory D.B., Rocco E.R., Miranda W.L., Kasamatsu T., Crispim F., Dib S.A. Prevalence of vitamin D receptor gene polymorphisms FokI and BsmI in Brazilian individuals with type 1 diabetes and their relation to β-cell autoimmunity and to remaining β-cell function. Hum. Immunol. 2009, 70:447-451.
28. Motohashi Y., Yamada S., Yanagawa T. Vitamin D receptor gene polymorphism affects onset pattern of type 1 diabetes. J. Clin. Endocrinol. Metab. 2003, 88:3137-3140.
29. Muller K., Bendtzen K. Inhibition of human T lymphocyte proliferation and cytokine production by 1,25-dihydroxyvitamin D3. Differential effects on CD45RA+ and CD45RO+ cells. Autoimmunity 1992, 14:37-43.
30. Panierakis C., Goulielmos G., Mamoulakis D., Petraki E., Papavasiliou E., Galanakis E. Vitamin D receptor gene polymorphisms and susceptibility to type 1 diabetes in Crete Greece. Clin. Immunol. 2009, 133:276-281.
31. Penna G., Adorini L. 1 Alpha, 25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J. Immunol. 2000, 164:2405-2411.
32. Pozzilli P., et al. Low levels of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 in patients with newly diagnosed type 1 diabetes. Horm. Metab. Res. 2005, 37:680-683.
33. Pugliese A. Genetics of type 1 diabetes. Endocrinol. Metab. Clin. N. Am. 2004, 33:1-16.
34. Ramos-Lopez E., Brück P., Jansen T., Herwig J., Badenhoop K. CYP2R1 (vitamin D 25-hydroxylase) gene is associated with susceptibility to type 1 diabetes and vitamin D levels in German. Diabetes Metab. Res. Rev. 2007, 23:631-636.
35. Rigby W.F., Stacy T., Fanger M.W. Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol). J. Clin. Investig. 1984, 74:1451-1455.
36. Rose C.J. Vitamin D insufficiency. N. Engl. J. Med. 2011, 364:248-254.
37. Rovner A.J., O'brien K.O. Hypovitaminosis D among healthy children in the United States: a review of the current evidence. Arch. Pediatr. Adolesc. Med. 2008, 162:513-519.
38. Sandler S., Buschard K., Bendtzen K. Effects of 1,25-dihydroxyvitamin D3 and the analogues MC903 and KH1060 on inteleukin-1 beta-cell function in vitro. Immunol. Lett. 1994, 41:73-77.
39. Shimada A., et al. Evidence for association between vitamin D receptor BsmI polymorphism and type 1 diabetes in Japanese. J. Autoimmun. 2008, 30:207-211.
40. Svoren B.M., Volkening L.K., Wood J.R., Laffel L.M. Significant vitamin D deficiency in youth with type 1 diabetes mellitus. J. Pediatr. 2009, 154:132-134.
41. Tsoukas C.D., Provvedini D.M., Manolagas S.C. 1,25 dihydroxyvitamin D3: a novel immunoregulatory hormone. Science 1984, 224:1438-1440.
42. Turpeinen H., Hermann R., Vaara S. Vitamin D receptor polymorphisms: no association with type 1 diabetes in the Finnish population. Eur. J. Endocrinol. 2003, 149:591-596.
43. Van Etten E., et al. The vitamin D receptor gene FokI polymorphism: functional impact on the immune system. Eur. J. Immunol. 2007, 37:395-405.
44. Yokota I., et al. Association between vitamin D receptor genotype and age of onset in juvenile Japanese patients with type 1 diabetes. Diabetes Care 2002, 25:1244-1250.
45. Zemunik T., et al. FokI polymorphism, vitamin D receptor, and interleukin-1 receptor haplotypes are associated with type 1 diabetes in the Dalmatian population. J. Mol. Diagn. 2005, 7:600-604.
46. Zhang J., et al. Polymorphisms in the vitamin D receptor gene and type 1 diabetes mellitus risk: an update by meta-analysis. Mol. Cell. Endocrinol. 2012, 355:135-142.